BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19567509)

  • 1. Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes.
    Breyer JP; McReynolds KM; Yaspan BL; Bradley KM; Dupont WD; Smith JR
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2137-44. PubMed ID: 19567509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study.
    Camp NJ; Farnham JM; Wong J; Christensen GB; Thomas A; Cannon-Albright LA
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1290-4. PubMed ID: 19336566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.
    Zheng SL; Sun J; Cheng Y; Li G; Hsu FC; Zhu Y; Chang BL; Liu W; Kim JW; Turner AR; Gielzak M; Yan G; Isaacs SD; Wiley KE; Sauvageot J; Chen HS; Gurganus R; Mangold LA; Trock BJ; Gronberg H; Duggan D; Carpten JD; Partin AW; Walsh PC; Xu J; Isaacs WB
    J Natl Cancer Inst; 2007 Oct; 99(20):1525-33. PubMed ID: 17925536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease.
    Teerlink CC; Thibodeau SN; McDonnell SK; Schaid DJ; Rinckleb A; Maier C; Vogel W; Cancel-Tassin G; Egrot C; Cussenot O; Foulkes WD; Giles GG; Hopper JL; Severi G; Eeles R; Easton D; Kote-Jarai Z; Guy M; Cooney KA; Ray AM; Zuhlke KA; Lange EM; Fitzgerald LM; Stanford JL; Ostrander EA; Wiley KE; Isaacs SD; Walsh PC; Isaacs WB; Wahlfors T; Tammela T; Schleutker J; Wiklund F; Grönberg H; Emanuelsson M; Carpten J; Bailey-Wilson J; Whittemore AS; Oakley-Girvan I; Hsieh CL; Catalona WJ; Zheng SL; Jin G; Lu L; Xu J; ; Camp NJ; Cannon-Albright LA
    Hum Genet; 2014 Mar; 133(3):347-56. PubMed ID: 24162621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A haplotype at chromosome Xq27.2 confers susceptibility to prostate cancer.
    Yaspan BL; McReynolds KM; Elmore JB; Breyer JP; Bradley KM; Smith JR
    Hum Genet; 2008 May; 123(4):379-86. PubMed ID: 18350320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study.
    Fesinmeyer MD; Kwon EM; Fu R; Ostrander EA; Stanford JL
    Prostate; 2011 Oct; 71(14):1538-47. PubMed ID: 21360564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.
    Robbins CM; Hernandez W; Ahaghotu C; Bennett J; Hoke G; Mason T; Pettaway CA; Vijayakumar S; Weinrich S; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD; Kittles RA
    Prostate; 2008 Dec; 68(16):1790-7. PubMed ID: 18767027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).
    Jin G; Lu L; Cooney KA; Ray AM; Zuhlke KA; Lange EM; Cannon-Albright LA; Camp NJ; Teerlink CC; Fitzgerald LM; Stanford JL; Wiley KE; Isaacs SD; Walsh PC; Foulkes WD; Giles GG; Hopper JL; Severi G; Eeles R; Easton D; Kote-Jarai Z; Guy M; Rinckleb A; Maier C; Vogel W; Cancel-Tassin G; Egrot C; Cussenot O; Thibodeau SN; McDonnell SK; Schaid DJ; Wiklund F; Grönberg H; Emanuelsson M; Whittemore AS; Oakley-Girvan I; Hsieh CL; Wahlfors T; Tammela T; Schleutker J; Catalona WJ; Zheng SL; Ostrander EA; Isaacs WB; Xu J;
    Hum Genet; 2012 Jul; 131(7):1095-103. PubMed ID: 22198737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11.
    Lu L; Sun J; Isaacs SD; Wiley KE; Smith S; Pruett K; Zhu Y; Zhang Z; Wiklund F; Grönberg H; Walsh PC; Chang BL; Zheng SL; Isaacs WB; Xu J
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2132-6. PubMed ID: 19549809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication of prostate cancer risk loci in a Japanese case-control association study.
    Yamada H; Penney KL; Takahashi H; Katoh T; Yamano Y; Yamakado M; Kimura T; Kuruma H; Kamata Y; Egawa S; Freedman ML
    J Natl Cancer Inst; 2009 Oct; 101(19):1330-6. PubMed ID: 19726753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline variation at 8q24 and prostate cancer risk in men of European ancestry.
    Matejcic M; Saunders EJ; Dadaev T; Brook MN; Wang K; Sheng X; Olama AAA; Schumacher FR; Ingles SA; Govindasami K; Benlloch S; Berndt SI; Albanes D; Koutros S; Muir K; Stevens VL; Gapstur SM; Tangen CM; Batra J; Clements J; Gronberg H; Pashayan N; Schleutker J; Wolk A; West C; Mucci L; Kraft P; Cancel-Tassin G; Sorensen KD; Maehle L; Grindedal EM; Strom SS; Neal DE; Hamdy FC; Donovan JL; Travis RC; Hamilton RJ; Rosenstein B; Lu YJ; Giles GG; Kibel AS; Vega A; Bensen JT; Kogevinas M; Penney KL; Park JY; Stanford JL; Cybulski C; Nordestgaard BG; Brenner H; Maier C; Kim J; Teixeira MR; Neuhausen SL; De Ruyck K; Razack A; Newcomb LF; Lessel D; Kaneva R; Usmani N; Claessens F; Townsend PA; Gago-Dominguez M; Roobol MJ; Menegaux F; Khaw KT; Cannon-Albright LA; Pandha H; Thibodeau SN; Schaid DJ; ; Wiklund F; Chanock SJ; Easton DF; Eeles RA; Kote-Jarai Z; Conti DV; Haiman CA
    Nat Commun; 2018 Nov; 9(1):4616. PubMed ID: 30397198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8q24 genetic variation and comprehensive haplotypes altering familial risk of prostate cancer.
    Dupont WD; Breyer JP; Plummer WD; Chang SS; Cookson MS; Smith JA; ; Blue EE; Bamshad MJ; Smith JR
    Nat Commun; 2020 Mar; 11(1):1523. PubMed ID: 32251286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk.
    Salinas CA; Kwon E; Carlson CS; Koopmeiners JS; Feng Z; Karyadi DM; Ostrander EA; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1203-13. PubMed ID: 18483343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk.
    Helfand BT; Fought AJ; Loeb S; Meeks JJ; Kan D; Catalona WJ
    J Urol; 2010 Aug; 184(2):501-5. PubMed ID: 20620408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family-based association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L3 region on chromosome 22q12 as a risk locus.
    Johanneson B; McDonnell SK; Karyadi DM; Quignon P; McIntosh L; Riska SM; FitzGerald LM; Johnson G; Deutsch K; Williams G; Tillmans LS; Stanford JL; Schaid DJ; Thibodeau SN; Ostrander EA
    Hum Mol Genet; 2010 Oct; 19(19):3852-62. PubMed ID: 20631155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population.
    Agalliu I; Leanza SM; Smith L; Trent JM; Carpten JD; Bailey-Wilson JE; Burk RD
    Prostate; 2010 Nov; 70(15):1716-27. PubMed ID: 20564318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestry.
    Pal P; Xi H; Guha S; Sun G; Helfand BT; Meeks JJ; Suarez BK; Catalona WJ; Deka R
    Prostate; 2009 Oct; 69(14):1548-56. PubMed ID: 19562729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.
    Beuten J; Gelfond JA; Franke JL; Shook S; Johnson-Pais TL; Thompson IM; Leach RJ
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):588-99. PubMed ID: 20086112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.
    Gudmundsson J; Sulem P; Rafnar T; Bergthorsson JT; Manolescu A; Gudbjartsson D; Agnarsson BA; Sigurdsson A; Benediktsdottir KR; Blondal T; Jakobsdottir M; Stacey SN; Kostic J; Kristinsson KT; Birgisdottir B; Ghosh S; Magnusdottir DN; Thorlacius S; Thorleifsson G; Zheng SL; Sun J; Chang BL; Elmore JB; Breyer JP; McReynolds KM; Bradley KM; Yaspan BL; Wiklund F; Stattin P; Lindström S; Adami HO; McDonnell SK; Schaid DJ; Cunningham JM; Wang L; Cerhan JR; St Sauver JL; Isaacs SD; Wiley KE; Partin AW; Walsh PC; Polo S; Ruiz-Echarri M; Navarrete S; Fuertes F; Saez B; Godino J; Weijerman PC; Swinkels DW; Aben KK; Witjes JA; Suarez BK; Helfand BT; Frigge ML; Kristjansson K; Ober C; Jonsson E; Einarsson GV; Xu J; Gronberg H; Smith JR; Thibodeau SN; Isaacs WB; Catalona WJ; Mayordomo JI; Kiemeney LA; Barkardottir RB; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
    Nat Genet; 2008 Mar; 40(3):281-3. PubMed ID: 18264098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer risk associated loci in African Americans.
    Xu J; Kibel AS; Hu JJ; Turner AR; Pruett K; Zheng SL; Sun J; Isaacs SD; Wiley KE; Kim ST; Hsu FC; Wu W; Torti FM; Walsh PC; Chang BL; Isaacs WB
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2145-9. PubMed ID: 19549807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.